XML 67 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Stock Options
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Stock Options    
Stock Options
5.Stock Options

The Company has adopted a stock option plan covering the issuance of up to 4,000,000 shares of Common Stock to qualified individuals. Options granted under this plan vest over four years and expire ten years from the date of the grant. The following table summarizes stock option activity for the three months ended March 31, 2023:

    

Option

    

Weighted-Average

    

Weighted-Average

Number of

Exercise

Remaining

    

Shares

    

Price Per Share

    

Contractual Term

Options outstanding as of January 1, 2023

 

4,851,666

$

1.91

 

8.4

Granted

 

58,000

 

1.81

 

  

Exercised

 

 

 

  

Canceled

 

 

 

  

Options outstanding as of March 31, 2023

 

4,909,666

$

1.91

 

8.2

Options exercisable as of March 31, 2023

 

1,906,098

$

1.68

 

7.1

Stock-based compensation expense resulting from granted stock options was $368,140 and $76,973 for the three months ended March 31, 2023 and 2022, respectively. Unrecognized stock-based compensation expense of $6,843,566 at March 31, 2023 will be recognized in future periods as the related stock options continue to vest over a weighted-average period of 3.32 years.

9.Stock Options

The Company has adopted a stock option plan covering the issuance of up to 4,000,000 shares of Common Stock to qualified individuals. Options granted under this plan vest over four years and expire ten years from the date of the grant. The following table summarizes stock option activity for the years ended December 31, 2022 and 2021:

    

Option

    

Option

    

Weighted-Average

Number of

Exercise

Exercise

    

Shares

    

Price Per Share

    

Price Per Share

Options outstanding at January 1, 2021

 

2,709,964

$0.30 - $2.00

 

$

1.48

Granted

 

335,300

$3.13 - $3.76

 

$

3.17

Exercised

 

 

 

Canceled

 

(286,000)

$0.30 - $3.13

 

$

1.70

Options outstanding at December 31, 2021

 

2,759,264

$0.30 - $3.76

 

$

1.66

Granted

2,149,152

$1.67 - $5.00

$

2.19

Exercised

Canceled

(56,750)

$0.30 - $2.00

$

0.49

Options outstanding at December 31, 2022

4,851,666

$0.30 - $5.00

$

1.91

Options exercisable at December 31, 2022

 

1,592,088

$0.30 - $3.76

 

$

1.49

Stock-based compensation expense resulting from granted stock options was $743,274 and $205,629 for the years ended December 31, 2022 and 2021, respectively. Unrecognized stock-based compensation expense of $6,900,425 at December 31, 2022 will be recognized in future periods as the related stock options continue to vest. The weighted-average remaining contractual life of previously granted stock options was 8.40 years at December 31, 2022.

The grant-date fair values of stock options granted in 2022 and 2021 was $3.16 and $1.53, respectively, and were estimated using a Black-Scholes valuation model with the following assumptions:

    

December 31,

    

December 31,

 

2022

2021

 

Expected term

 

7.21

years

7.0

years

Volatility

 

27.03

%  

30.3

%

Dividend rate

 

0.0

%  

0.0

%

Discount rate

 

3.32

%  

1.2

%